Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors
Cryptococcus neoformans is a common cause of meningoencephalitis among AIDS patients. Several C. neoformans virulence factors have been identified, but the relative importance of particular factors is unknown. This study examined the corrrelation of the virulence of 18 C. neoformans var. grubii isolates from AIDS patients with the expression of several well-described virulence factors. The LD50 at 15 days after intracranial inoculation of ICR mice was <100 c.f.u. for 22 % of isolates, 100–1000 for 28 %, 1000–10 000 for 11 % and >20 000 for 39 %. Higher cryptococcal concentrations in brains were noted for isolates with lower LD50 (P=0.002). In survival studies, no immunocompetent BALB/c mice (nu/−) infected with 3×LD50 of three virulent isolates (LD50=62, 99, 1280) survived beyond 23 days, whereas 100 %, 90 % and 90 % of mice infected with 20 000 c.f.u. of three hypovirulent isolates (LD50>20 000) survived for 60 days (P<0.0001). Even among BALB/c nude (nu/nu) mice, survival rates over 60 days were 100 %, 70 % and 50 %, respectively, for the hypovirulent isolates. Growth rate at 37 °C and capsule size within brains correlated with LD50 by univariate (P=0.0001 and 0.028, respectively) and multivariate (P=0.017 and 0.016, respectively) analyses. There was no correlation between LD50 and capsule size in vitro, phospholipase activity, melanin formation, proteinase activity and fluconazole MIC. In conclusion, AIDS patients are susceptible to infection by C. neoformans isolates of wide-ranging virulence, including isolates that are markedly hypovirulent. The virulence of a given isolate reflects a composite of factors rather than the contribution of a dominant factor. Growth at 37 °C and capsule size in vivo make particularly important contributions.
AndradeV. S, SarubboL. A, FukushimaK, MiyajiM, NishimuraK, de Campos-TakakiG. M. 2002; Production of extracellular proteases by Mucor circinelloides using d-glucose as carbon source/substrate. Braz J Microbiol 33:106–110
BarchiesiF, CogliatiM, EspostoM. C, SpreghiniE, SchimizziA. M, WickesB. L, ScaliseG, VivianiM. A.
2005; Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis. J Infect 51:10–16[CrossRef]
BlackstockR, MurphyJ. W.
1997; Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans . Infect Immun 65:4114–4121
BlasiE, BarluzziR, MazzollaR, MosciP, BistoniF.
1992; Experimental model of intracerebral infection with Cryptococcus neoformans : roles of phagocytes and opsonization. Infect Immun 60:3682–3688
BlasiE, BarluzziR, MazzollaR, TanciniB, SaleppicoS, PulitiL, PitzurraM, BistoniF.
1995; Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol 58:111–116[CrossRef]
ChangY. C, Kwon-ChungJ. K.
1994; Complementation of a capsule-deficiency mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14:4912–4919
ChangY. C, Kwon-ChungJ. K.
1998; Isolation of the third capsule-associated gene, CAP60 , required for virulence in Cryptococcus neoformans . Infect Immun 66:2230–2236
ChangY. C, Kwon-ChungJ. K.
1999; Isolation, characterization, and localization of a capsule-associated gene, CAP10 , of Cryptococcus neoformans . J Bacteriol 181:5636–43
ChangY. C, PenoyerL. A, Kwon-ChungK. J.
1996; The second capsule gene of Cryptococcus neoformans, Cap64 , is essential for virulence. Infect Immun 64:1977–1983
ChenS. C. A, MullerM, ZhouJ. Z, WrightL. C, SorrellT. C.
1997; Phospholipase activity in Cryptococcus neoformans : a new virulence factor?. J Infect Dis 175:414–420[CrossRef]
CoxG. M, McDadeH. C, ChenS. C. A. 8 other authors2001; Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans . Mol Microbiol 39:166–175[CrossRef]
DixonD. M, PolakA.
1986; In vivo and in vitro studies with an atypical, rhinotrophic isolate of Cryptococcus neoformans . Mycopathologia 96:33–96 40 [CrossRef]
DongZ. M, MurphyJ. W.
1995; Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun 63:2632–2644
FeldmesserM, KressY, CasadevallA.
2001; Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355–65
FranzotS. P, MukherjeeJ, CherniakR, ChenL, HamdanJ. S, CasadevallA.
1998; Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66:89–97
FriesB. C, CasadevallA.
1998; Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis 178:1761–1766[CrossRef]
FromtlingR. A, AbruzzoG. K, RuizA.
1988; Cryptococcus neoformans : a central nervous system isolate from an AIDS patient that is rhinotropic in a normal mouse model. Mycopathologia 102:72–86
GrosseG, MishraS. K, StaibF.
1975; Selective involvement of the brain in experimental murine cryptococcosis. II. Histopathological observations. Zentralbl Bakteriol 230:518–533
IwataK, YamashitaT, OhsumiM, BabaM, NaitoN, TakiA, YamadaN.
1990; Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutants of Cryptococcus neoformans . J Med Vet Mycol 28:77–90[CrossRef]
Kwon-ChungK. J, PolacheckI, PopkinT. J.
1982; Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 150:1414–1421
LeightonT. J, DoiR. H, WarrenR. A. J, KellnR. A.
1973; The relationship of serine protease activity to RNA polymerase modification and sporulation in Bacillus subtilis . J Mol Biol 76:103–122[CrossRef]
MitchellT. G, PerfectJ. R.
1995; Cryptococcosis in the era of AIDS – 100 years after the discovery of Cryptococcus neoformans . Clin Microbiol Rev 8:515–548
National Committee for Clinical Laboratory Standards1997Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts . Approved standard. Document M-27A Wayne, PA: National Committee for Clinical Laboratory Standards;
NielsenK, CoxG, WangP, ToffalettiD, PerfectJ. R, HeitmanJ.
2003; Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and α isolates. Infect Immun 71:4831–4841[CrossRef]
NosanchukJ. D, CasadevallA.
2003; Budding of melanized Cryptococcus neoformans in the presence or absence of l-dopa. Microbiology 149:1945–1951[CrossRef]
NoverrM. C, WilliamsonP. R, FajardoR. S, HuffnagleG. B.
2004; CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun 72:1693–1699[CrossRef]
PolacheckI, HearingV. J, Kwon-ChungK. J.
1982; Biochemical studies of phenoloxidase and utilization of catechalamines in Cryptococcus neoformans . J Bacteriol 150:1212–1220
Polak-WyssA.
1991; Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses 34:205–215
RhodesJ. C, PolacheckI, Kwon-ChungK. J.
1982; Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans . Infect Immun 36:1175–1184
SalasS. D, BennettJ. E, Kwon-ChungK. L, PerfectJ. R, WilliamsonP. R.
1996; Effect of the laccase gene CNLAC1 , on virulence of Cryptococcus neoformans . J Exp Med 184:377–86[CrossRef]
VanbreuseghemR.
1967; White mice sensitivity to Cryptococcus neoformans . Production of resistance against a cerebral inoculation. Ann Soc Belg Med Trop 47:281–294
Van CutsemJ, FransenJ, Van GervenF, JanssenP. A. J.
1986; Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermatropism in guinea pigs. Mykosen 29:561–575
VecchiarelliA, RetiniC, PietrellaD, MonariC, TasciniC, BeccariT, KozelT. T.
1995; Down-regulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 63:2919–2923
VelezJ. D, AllendoerferR. R, LutherM, RinaldiM. G, GraybillJ. R.
1993; Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J Infect Dis 168:508–510[CrossRef]
Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors